{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:43:29Z","timestamp":1790405009527,"version":"4.1.0"},"reference-count":46,"publisher":"Universa BV","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AGEB"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Amyloidosis is a very rare condition, which, due to its rarity, is often missed or diagnosed in an advanced stage of the disease, causing significant morbidity and mortality. In this review we describe the existing types of amyloidosis focusing on the gastro-intestinal tract. Amyloidosis occurs when abnormal protein fibrils (amyloid) deposit in the muscularis mucosae. This can cause an array of symptoms ranging from (in order of occurrence): gastro-intestinal bleeding, heartburn, unintentional weight loss, early satiety, constipation, diarrhea, nausea, vomiting and fecal incontinence (1). Treatment is focused on the underlying condition (if any) causing the production and deposition of the abnormal fibrils, in combination of symptomatic treatment.<\/jats:p>","DOI":"10.51821\/85.1.8499","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T20:45:21Z","timestamp":1647377121000},"page":"80-84","source":"Crossref","is-referenced-by-count":3,"title":["Isolated amyloidosis of the gastro-intestinal tract"],"prefix":"10.51821","volume":"85","author":[{"given":"S","family":"Smeets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dedeurwaerdere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Thomaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Houthoofd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"D\u2019Hulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wilmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Offner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"De Coninck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27062","published-online":{"date-parts":[[2022,3]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"WIXNER J., MUNDAYAT R., KARAYAL O., ANAN I., KARLING P., SURH O., et al. THAOS investigators. THAOS: Gastrointestinal manifestations of transthyretin amyloidosis \u2013 common complications of a rare disease. Journal of Rare Diseases., 2014, 9: 6.","DOI":"10.1186\/1750-1172-9-61"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"ROWE K.,PANKOW J., NEHME F., SALYERS W. Gastrointestinal Amyloidosis: Review of the Literature. Cureus., 2017, 9(5): 1-6.","DOI":"10.7759\/cureus.1228"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"SIPE JD., BENSON MD., BUXBAUM JN., SHU-ICHI I., GIAMPAOLO M., MARIA J., et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid., 2014, 21: 221-224.","DOI":"10.3109\/13506129.2014.964858"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"WESTERMARK P. Aspects on human amyloid forms and their fibril polypeptides. Febs j., 2005, 272: 5942-5949.","DOI":"10.1111\/j.1742-4658.2005.05024.x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"SAWAYA MR., SAMBASHIVAN S., NELSON R., IVANOVA M., SIEVERS S., APOSTOL M., et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature., 2007, 447: 453-457.","DOI":"10.1038\/nature05695"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"BONAR L., COHEN A., SKINNER M. Characterization of the amyloid fibril as a cross-beta protein. Proc Soc Exp Biol Med., 1969, 131: 1373-1375.","DOI":"10.3181\/00379727-131-34110"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"GLENNER G., TERRY W. Characterization of amyloid. Annu Rev Med.,1974, 25: 131-135.","DOI":"10.1146\/annurev.me.25.020174.001023"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"SUNDE M., SERPELL L., BARTLAM M., FRASER P.,PEPYS M., BLAKE C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol., 1997, 273: 729-739.","DOI":"10.1006\/jmbi.1997.1348"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"WECHALEKAR A., GILLMORE J., HAWKINS P. Systemic amyloidosis. Lancet., 2015, 387: 2641-2654.","DOI":"10.1016\/s0140-6736(15)01274-x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"PALLADINI G, MERLINI G. What is new in diagnosis and management of light chain amyloidosis? Blood. 2016, 128: 159-168.","DOI":"10.1182\/blood-2016-01-629790"},{"key":"ref10","unstructured":"KYLE R., GERTZ M. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol.,1995, 32: 45-59."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"EBERT E., NAGARM. Gastrointestinal Manifestations of Amyloidosis. American Journal of Gastroenterology., 2008, 103: 776-787.","DOI":"10.1111\/j.1572-0241.2007.01669.x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"CAMPISTOL J., ARGILES A. Dialysis-related amyloidosis: Visceral involvement and protein constituents. Nephrol Dial Transplant., 1996, 11: 142-145.","DOI":"10.1093\/ndt\/11.supp3.142"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"DULGHERU E., BALOS L., BAER A. Gastrointestinal complications of \u03b22-microglobulin amyloidosis: A case report and review of the literature. Arthritis Rheum., 2005, 53: 142-145.","DOI":"10.1002\/art.20917"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"JIMENEZ R., PINKUS G., OWEN W., LAZARUS M., KAY J., TURNER J. Development of gastrointestinal \u03b22-microglobulin amyloidosis correlates with time on dialysis. Am J Surg Pathol., 1998, 22: 729-735.","DOI":"10.1097\/00000478-199806000-00010"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"FRIEDMAN S., JANOWITZ H., Systemic amyloidosis and the gastro-intestinal tract. Gastroenterol Clin North Am., 1998, 27: 595-614.","DOI":"10.1016\/s0889-8553(05)70022-4"},{"key":"ref16","unstructured":"GAL R., KORZETS A., SCHWARTZ A., RATH-WOLFSON L., GAFTER U. Systemic distribution of \u03b2 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Arch Pathol Lab Med., 1994, 118: 718-21."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"COWAN A., SKINNER M., SELDIN C., BERK J., LICHTENSTEIN D., O\u2019HARA C., et al. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica., 2013, 98: 141-146.","DOI":"10.3324\/haematol.2012.068155"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"OLSSON M., HELLAMN U., PLANTE-BORDENEUVE V., JONASSON J., LANG K ., SUHR O. Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients. Clin Genet., 2009, 75: 163-168.","DOI":"10.1111\/j.1399-0004.2008.01097.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"ROCKEN C., SAEGER W., LINKE R. Gastrointestinal amyloid deposits in old age. Report on 110 consecutive autopsical patients and 98 retrospective bioptic specimens. Pathol Res Pract., 1994, 190: 641-649.","DOI":"10.1016\/s0344-0338(11)80742-9"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"MATSUTANI H., HOSHII Y., SETOGUCHI M., KAWANO H., GONDO T., TAKAHASHI M., et al. Vascular amyloid of unknown origin and senile transthyretin amyloid in the lung and gastrointestinal tract of old age: Histological and immunohistochemical studies. Pathol Int., 2001, 51: 326-332.","DOI":"10.1046\/j.1440-1827.2001.01213.x"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"KAMEYAMA H., NAKAJIMA H., NISHITSUJI K., MIKAWA S., UCHIMURA K., KOBAYASHI N., et all. Iowa Mutant Apolipoprotein A-I (ApoA-IIowa) Fibrils Target Lysosomes. Sci Rep., 2016, 6: 30391.","DOI":"10.1038\/srep30391"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"ERIKSSON M., SCH\u00d6NLAND S., YUMLU S., HEGENBART U., VON HUTTEN H., GIOEVA Z., et al. Hereditary Apolipoprotein AI-Associated Amyloidosis in Surgical Pathology Specimens. J Mol Diagn., 2009, 11(3): 257-262.","DOI":"10.2353\/jmoldx.2009.080161"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"PINNEY J., SMITH C., TAUBE J., LACHMAN H., VENNER C., GIBBS S., et al. Systemic amyloidosis in England: an epidemiological study. Br. J. Haematol., 2013, 161: 525-532.","DOI":"10.1111\/bjh.12286"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"HEMMINKI K., LI X., F\u00d6RSTI A., SUNDQUIST J., SUNDQUIST K. Incidence and survival in non-hereditary amyloidosis in Sweden. BMC Public Health., 2012, 12: 974.","DOI":"10.1186\/1471-2458-12-974"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"SYEDA U., CHING COMPANIONI R., ALKHAWAMA H., WALFISH A. Amyloidosis of the gastrointestinal tract and the liver: clinical context, diagnosis and management. European Journal of Gastroenterology & Hepatology., 2016, 28: 1109-1121.","DOI":"10.1097\/meg.0000000000000695"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"SATTIANAYAGAM P., HAWKINS P., GILLMORE J. Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol., 2009, 6: 608-617.","DOI":"10.1038\/nrgastro.2009.147"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"SEKIJIMA Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. Journal of Neurology, Neurosurgery & Psychiatry., 2015, 86: 1036-1043.","DOI":"10.1136\/jnnp-2014-308724"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"FREUDENTHALER S., HEGENBART U., SCH\u00d6NLAND S., BEHRENS H., KR\u00dcGER S., R\u00d6CKEN C. Amyloid in biopsies of the gastrointestinal tract-a retrospective observational study on 542 patients. Virchows Arch., 2016, 5: 468-569.","DOI":"10.1007\/s00428-016-1916-y"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"MENKE D., KYLE R., FLEMMING C., WOLFE J., KURTIN P., OLDENBURG W. Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc., 1993, 68: 763-767.","DOI":"10.1016\/s0025-6196(12)60634-x"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"FONNESU C., GIOVINALE M., VERRECCHIA E., DE SOCCIO G., CERQUAGLIA C., CURIGLIANO V., et al. Gastrointestinal amyloidosis: a case of chronic diarrhoea. Eur Rev Med Pharmacol Sci., 2009, 13: 45-50.","DOI":"10.1016\/s1590-8658(08)60468-5"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"KIM S., KANG E., PARK J., JO J., KIM S., CHO J., et al. Gastrointestinal amyloidosis presenting with multiple episodes of gastrointestinal bleeding. Cardiovasc Intervent Radiol., 2009, 32: 577-580.","DOI":"10.1007\/s00270-008-9429-y"},{"key":"ref32","unstructured":"KAISERLING E., KROBER S. Massive intestinal hemorrhage associated with intestinal amyloidosis. An investigation of underlying pathologic processes. Gen Diagn Pathol., 1995, 141: 147-154."},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"HIRSCHFIELD G. Amyloidosis: a clinico-pathophysiological synopsis. Semin Cell Dev Biol., 2004, 15: 39-44.","DOI":"10.1016\/j.semcdb.2003.12.013"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"GERTZ M., BENSON M., DYCK P., GROGAN M., COELHO T., CRUZ M., et al. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. Journal of the American College of Cardiology., 2015, 66: 2451-2466.","DOI":"10.1016\/j.jacc.2015.09.075"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"OBICI L., SUHR O. Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis. Clinical Autonomic Research., 2019, 29(Suppl 1): S55-S63.","DOI":"10.1007\/s10286-019-00628-6"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"DISPENZIERI A., BUADI F., KUMAR S., REEDER C., SHER T., LACY M., et al. Treatment of immunoglobulin light chain amyloidosis: mayo stratification of myeloma and risk-adapted therapy (msmart) consensus statement. Mayo Clin Proc., 2015, 90: 1054-1081.","DOI":"10.4065\/82.3.323"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"TOSCA CUQUERELLA J., BOSCA-WATTS M., ANTON AUSEJO R., ALONSO S., DE MIGUEL F, PEREZ M. Amyloidosis in inflammatory bowel disease: a systematic review of epidemiology, clinical features, and treatment. J Crohns Colitis., 2016, 10: 1245-1253.","DOI":"10.1093\/ecco-jcc\/jjw080"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"POULLOS P., STOLLMAN N. Gastrointestinal Amyloidosis: Approach to Treatment. Curr Treat Options Gastroenterol., 2003, 6: 17-25.","DOI":"10.1007\/s11938-003-0029-2"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"TREGLIA G., GLAUDEMANS A., BERTAGNA F., HAZENBERG B., ERBA P., GIUBBINI R., et al. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta- analysis. European Journal of Nuclear Medicine and Molecular Imaging., 2018, 45: 1945-1955.","DOI":"10.1007\/s00259-018-4013-4"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"MARTINEZ-NAHARRO A., HAWKINS P., FONTANA M. Cardiac amyloi-dosis. Clin Med (Lond)., 2018, 18(Suppl 2): s30-s35.","DOI":"10.7861\/clinmedicine.18-2-s30"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"MANSO M., MARQUES D., ROCHA S., RODEIA S., DOMINGOS R. Senile Systemic Amyloidosis: An Underdiagnosed Disease. Eur J Case Rep Intern Med., 2017, 4(9): 000725.","DOI":"10.12890\/2017_000725"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"IHNE S., MORBACH C., SOMMER C., GEIER A., KNOPS., ST\u00d6RK S. Amyloidosis - the diagnosis and treatment of an underdiagnosed disease. Dtsch Artzebl int., 2020, 117: 159-166.","DOI":"10.3238\/arztebl.2020.0159"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"HWAN KWON Y., YEON KIM J., HUN KIM J., WOO PARK H., MIN YANG H., WOO JEON S., et al. A case of primary colon amyloidosis presenting as hematochezia. Korean J Gastroenterol., 2012, 59(1): 44-47.","DOI":"10.4166\/kjg.2012.59.1.44"},{"key":"ref44","unstructured":"RACANELLI V., D\u2019AMORE F. Localized AL amyloidosis of the colon and clinical features of intestinal obstruction. A case report. Ann Ital Med Int., 1999, 14: 58-60."},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"PINNEY J., WHELAN C., PETRIE A., DINGU J., BANYPERSAD S., SATTIANAYAGAM P., et al. Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome. J Am Heart Assoc., 2013, 2: e000098.","DOI":"10.1161\/jaha.113.000098"}],"container-title":["Acta Gastro Enterologica Belgica"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T01:13:14Z","timestamp":1647738794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ageb.be\/ageb-journal\/ageb-volume\/ageb-article\/1988\/Isolated%20amyloidosis%20of%20the%20gastro-intestinal%20tract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022]]},"published-print":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.51821\/85.1.8499","relation":{},"ISSN":["1784-3227"],"issn-type":[{"value":"1784-3227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}